|Publication number||USRE24899 E|
|Publication date||29 Nov 1960|
|Filing date||30 Jun 1953|
|Priority date||30 Jun 1953|
|Also published as||DE1010822B, DE1017905B, US2800458|
|Publication number||US RE24899 E, US RE24899E, US-E-RE24899, USRE24899 E, USRE24899E|
|Export Citation||BiBTeX, EndNote, RefMan|
|Referenced by (79), Classifications (26)|
|External Links: USPTO, USPTO Assignment, Espacenet|
OIL-CONTAINING MICROSCOPIC CAPSULES AND METHOD OF MAKING THEM Original Filed June 30, 1953 4 Sheets-Sheet 1 NOV. 1960 B K GREEN I Re. 24, 899
MICROSCOPIC OIL" CONTAINING CAPSULES OF GELLED HYDROPHILIC COLLOID MATERIAL MAGNIFICATION 800 X GELATIN CAPSULES CONTAINING TRICHLORODIPHENYL DROPLETS, THE CAPSULES BEING SPARSELY DISPERSED IN WATER TO SHOW INDIVIDUALLY INVENTOR BARRETT K. GREEN Nov. 29, 1950 B. K. GREEN R OIL-CONTAINING MICROSCOPIC CAPSULES e z4899 AND METHOD OF MAKING THEM Original Filed June 30, 1953 4 Sheets-Sheet 2 FIG. 2
MAKE AN EMULSION OF OIL AND A GELLABLE COLLOID AQUEOUS SOL COACERVATE BY ADDITION OF AN AQUEOUS SALT SOLUTION STEPS ABOVE THIS LINE PREFORMED AT TEMPERATURE, ABOVE MELTING POINT OF THE COLLOID SOL GEL THE COLLOID BY POURING COACERVATE MIXTURE IN COOL SALT SOLUTION WASH WITH WATER AND FILTER TO REMOVE THE SALT HARDEN FILTER CAKE WITH SOLUTION OF FORMALDEHYDE IN WATER WASH WITH WATER AND FILTER TO REMOVE RESIDUAL FORMAL DEHYDE ADJUST WATER CONCENTRATION TO DESIRED AMOUNT INVENTOR BARRETT K. GREEN HIS ATTORNEYS Nov. 29, 1960 a. K. GREEN 24,399
' OIL-CONTAINING MICROSCOPIC CAPSULES AND METHOD OF MAKING THEM Original Filed June 30, 1953 4 Sheets-Sheet 3 FIG. 3
MAKE I GALLON OF AN OIL'IN'WATER EMULSION 0F 20 PARTS BY WEIGHT, 0F TRICHLORODIPHENYL AND I00 PARI'S,BY WEIGHT, OF A SOL OF 10%, av WEIGHT, OF GELATIN m WATER THE on. DROP SIZE OF WHICH IS 2-5 mcRdNs COACERVATE BY ADDING SLOWLY AND UNIFORMLY 4/IO GALLON OF 20%, BY WEIGHT, SODIUM SULPHATE IN WATER KEEP INGREDIENTS ABOVE THIS LINE AT 50C POUR THE RESULTING COACERVATE MIXTURE INTO IO GALLONS OF 7%, BY WEIGHT, OF SODIUM SULPHATE IN WATER AT I9C, TO GEL THE COLLOID FILTER AND WASH FILTER CAKE WITH WATER AT A TEMPERATURE BELOW THE MELTING POINT OF THE GELATIN, TO REMOVE THE SALT HARDEN WASHED FILTER CAKE MATERIAL WITH 2 GALLONS OF 37% SOLUTION OF FORMAL DEHYDE IN WATER FILTER AND WASH THE COACERVATE MATERIAL TO REMOVE THE RESIDUAL FORMALDEHYDE REMOVE RESIDUAL FLUID IF DESIRED I NVE NTOR BARRETT K. GREEN kew/0W Nov. 29, 1960 a GREEN Re. 24,899
K. OIL-CONTAINING MICROSCOPIC CAPSULES AND METHOD OF MAKING THEM Original Filed June 30, 1953 4 Sheets-Sheet 4 I00% WATER A ABOUT 50: 24 90% fee INVENTOR BARRETT K GREEN United States Patent OIL-CONTATNIN G MICROSCOPIC CAPSULES AND METHOD OF MAKING THEM Matter enclosed in heavy brackets appears in the original patent but forms no part of this reissue specifi- Lcation; :matter printed in italics indicates the additions made .by 1 reissue.
This :invention relates to oil-containing microscopic capsules .ofa'gelled hydrophilic coloid material and to -a-method of making them by salt-coacervation.
The microscopic oil-impermeable capsules, made in an aqueous medium, are .several microns in diameter, and :each contains, as a .central nucleus, oil surrounded by .a relatively and uniformly thick encapsulating wall of the;gelled colloid material. If the capsules are dispersedsin a -great deal of water they may exist individually, but if the free water is removed thecapsules tend to agglomerate like bunchesof grapes until'the mass becomes adherent and more or less solid.
.BY the process steps to be described, the colloid encapsulating material is rendered impermeable, as far as the .oil is concerned, so that it cannot escape until the capsule is ruptured. In this way the oil is contained protected against-environmental and otherdeleterious influences. In the event the free water is removed, the capsules may be treated asisolid material even though more than 50% of the weight of the mass may be oil .in liquid form. If desired, the capsules may be hardened and rendered insoluble so that the free water may be .drivenofibyheat, the dried material being immune to the destructive influence of'water and other equivalent solvents.
The oils which may be used in the process are the watervimmiscible oils which are inert as to the encapsulating material and which may tbe emulsified with an aqueous sol of the particular hydrophilic gellable colloid used. Among such oils are the mineral oils such as petroleum fractions; animal oils such as sperm .oil; fish oils such .as halibut liver oil; vegetable oils such as cotton .seed oil, corn oil, castor oil, and coconut oil; essential oils from plants, and synthetic oils such as methyl salicylate and chlorinated diphenyl.
Among the gellable hydrophilic colloid materials may be mentionedgelatin and agar-agar.
In the oil, that is usedto form the droplets which are surrounded by the encapsulating material, may be dissolved various selected materials, or dispersed solid materiaL-ofcolloidal size, such added substances, of course, being inert to the other ingredient materials. Among suchfine'lyoivided solid substances may be mentioned dyes such as are used in making inks, solid chemical reactant substances which will be described, medicines, perfumes, and. other materials which it is desired to have protected from the environment or which it is desired to have isolated for other reasons. Among substances which maybe dissolved in the oil may be mentioned oil- Reissuecl Nov. 29, 19.60
soluble dyes, adhesives, oil-soluble vitamins, and the like.
Among the most important uses for such material in an aqueous dispersion is as a paper coating composition which forms a transfer film. Theoil in the microscopic capsules so used would be of itself or contain a marking material which would be transferred to an underlying sheet by printing or marking pressures that rupture the capsules of the overlying transfer film, to cause said marks on the underlying sheet. Transfer films of rupturable type which contain oily droplets of marking fluid are disclosed in United States Patent No. 2,548,366, whichissued on the applicaiton ofBarrett K. Green, this applicant, and Robert W. Sandberg, but such disclosed films are not composed of capsules. Transfer films such as disclosed in said patent consistof a continuous film phase of gelled hydrophilic colloid material having fluid droplets of oil dispersed therethrough. The aforesaid continuous film afiords someuopportunity for escape of the fluid droplets because of the sponge-like texture of the colloid gel film surrounding the voids which hold the oil. Cracks in the films of the type disclosed in said patent will run right across the voids which 'hold the oil, releasing the oil. Such cracks may be caused by folding or rough handling of the material, or may be caused by unusualenvironmental conditions.
The product of this invention makes transfer films superior to thosedisclosed in said patent, int-hat cracks in the film formed by the capsular material of this invention do not runacross the capsules, but around them, so that the oil is notreleased by random cracks pro- .duced in'the film. Moreover, the pore size of the hydroiphilic colloid encapsulating film may be reduced during gelatin-n and drying to render the encapsulating film impermeable to theoil inside, as will be explained.
EBacaus-e all .films of gelled hydrophilic colloid material ,aretoa degree molecularly porous because of the nature of .gel structures, the capsules will be-more or less porous according to the control exercised in forming :them. If the gelation step is performed rapidly the pore vsize'will .be small and the capsules will retain, by sieve action, .oils having relatively small molecules. If the gelation step is performed slowly the pore structure of the encapsulating material will be coarser. The hardening step is carried out in a high pH environment, as will be described, which makes the capsules'harder, more heat resistant, and insoluble in water. If the capsules are used to hold marking fluids, small pores are desired, whereas if the capsules are to be used for other purposes where slow releaseof theoil from the capsules is desired, larger pores would be preferred. The process is flexible to achieve either condition.
If the capsules are to be dried, they may be dried in an oven and the resulting agglomerate material ground and washed to remove the oil which escaped during grinding, to form apparently dry granules or, if desired, the fluid-dispersed capsules may be spray dried, in which event no comminution or washing is necessary. In the .dry granular form the capsules containing the fluid oil are handled and stored in the same manner as other dry materials are handled and stored.
Therefore, it is an object of this invention to provide microscopic capsules of a gelled hydrophilic colloid material each having a centraloilnucleus.
It is another object of the invention to provide such capsules dispersed in a fluid.
It is an alternative object to provide such capsules in outwardly dry form.
It is further an object of the invention to provide microscopic oil-containing capsules of hydrophilic gelled colloid material in which the pore size of the encapsulating material was controlled by the conditions of its manufacture.
Another further object of the invention is to provide such oil-containing capsules in which the encapsulating material has been hardened.
With further objects in view which will become apparent in the specification to follow, the invention includes the use of novel ingredients and processing steps, some of which are optional, described with reference to the drawings which accompany and form part of this specification.
Of the drawings:
Fig. 1 is a reproduction of a micro-photograph of the capsules dispersed in a great amount of water, the magnification being about 800 diameters.
Fig. 2 is a block diagram showing the steps followed in making the gelled and hardened colloid capsules, this figure showing the process in general Without the specific recitation of ingredients and amounts of ingredients.
Fig. 3 shows the method in more specific form, with gelatin and trichlorodiphenyl as the ingredients, and with sodium sulphate as the salt.
Fig. 4 is a tertiary diagram showing the coacervation region of a sol of gelatin in water, using sodium sulphate as the salt.
\Fig. 5 is a ternary diagram showing the coacervation region of a sol of gelatin in water, using ammonium sulphate as the salt.
Referring to Fig. 2, the process, in general, includes the first step of forming an emulsion of oil and a gellable colloid aqueous sol. This is made by dispersing the colloid in water, adding the oil and forming an emulsion by stirring. Next, after having determined the coacervate region of the sol, by making a diagram as shown in Figs. 3 and 4, as will be described, a coacervate is formed by the addition of a proper amount of an aqueous solution of a suitable coacervating salt. In order that the colloid will not gel prematurely the foregoing steps are performed at a temperature above the melting point of the colloid sol. Thereafter, the colloid is gelled by pouring the coacervate mixture into a cool solution of the same salt which was used for the coacervation, causing the colloid deposited around the individual oil droplets to gel. This gelled colloid capsular mass is washed with water and filtered to remove the salt. If it is desired to harden and make the capsular material hard and insoluble, the filter cake is treated with a solution of formaldehyde. According to what use is to be made of the finished material, the free water is adjusted to the desired concentration, or the free water is removed entirely.
The preferred form of the invention, shown step by step in Fig. 3, utilizes gelatin, preferably high quality pigskin gelatin which has its iso-electric point at pH8. Inasmuch as the finished encapsulated material will find an important use in the making of coating compositions which will form a transfer film on record material, such as paper, the preferred oil used is trichlorodiphenyl which is relatively non-volatile, inert, and which can be ob tained in a colorless and pure form. Into this trichlorodiphenyl may be dissolved a colorless color-reactant such as the crystal violet lactone which is, as specified in the patent to which reference has been made, 3,3 bisCp-dimethylaminophenyl) 6-dimethylamino phthalide. The described phthalide compound has a white crystalline structure and, when dissolved to the extent of about 3%, by weight, in the trichlorodiphenyl and placed in contact with a sheet of paper sensitized with attapulgite, will turn to a dark blue color similar to crystal violet. When fluid-dispersed capsular material containing this oil is applied to a sheet and dried to form a transfer film, the capsules may be ruptured locally at points of printing and marking pressures to release the oil which will thereupon come in contact with the sensitized undersheet, as mentioned in said patent. In making up the preferred material, one gallon of an oil-in-water emulsion of 20 parts, by weight, of trichlorodiphenyl containing the phthalide and 100 parts, by weight, of a sol of 10%, by weight, of pigskin gelatin in water, is prepared, the emulsifying continuing until the drop size of the oil is from 2 to 5 microns. This material is kept at 50 centigrade to prevent the gelatin from gelling. With the temperature of the ingredient still kept at 50, the coacervation then is induced by adding, slowly and uniformly, four-tenths of a gallon of 20%, by weight, of sodium sulphate in water. During coacervation, the gelatin molecules are deposited uniformly about each oil droplet as a nucleus. The uniform addition of this material is accomplished by continuous agitation.
To gel the coacervate, the heated coacervate mixture is poured into 10 gallons of 7%, by Weight, of sodium sulphate in Water at 19 centigrade, with agitation. At this point the encapsulation of the oil with gelled hydrophilic material has taken place and the further steps are to put it in condition for use as is intended. The material is filtered and washed with water, the temperature being kept below the melting point of the gelatin, to remove the salt. If desired, the filtered material is hardened by combining it with 2 gallons of a 37% solution of formaldehyde in water. This hardened mass then is filtered and washed to remove the residual formaldehyde. The resulting filter cake is adjusted to the proper water content by the addition of water or the removal thereof, by ordinary means such as centrifuging or spray drying, and the material is ready for use. If this material is intended for paper coating composition it is kept in aqueous suspension and applied directly to the paper which is then dried leaving the capsules adherent to the paper and to each other in a film.
In determining under what conditions with particular materials coacervation takes place, resort may be had to the formation of a ternary diagram resulting from a testing of various amounts of pigskin gelatin and sodium sulphate solution, whereas Fig. 5 shows the results of testing various amounts of the same gelatin with an ammonium sulphate solution. In the causation of coacervation by use of a salt, the salt attracts water away from the colloid material causing the colloid material to separate or unmix, forming, in the vessel in which this step is taken, after they are allowed to separate by gravity, a colloidrich fluid in the bottom and a layer extremely poor in colloid material on top. The tests which are made to determine the coacervate region as far as amounts of material are concerned can be done with the colloid sol and the salt solution without the oil. Inasmuch as it is impractical to work with solutions of gelatin in which there is less than water, because of viscosity, the diagrams of Figs. 4 and 5 deal in that portion of the tenary scale above 80% water. The line 20 in Fig. 4 and the line 21 in Fig. 5 represent 80% water, the horizontal lines being indexed with the intermediate percentages of water. C0- acervation is noticed by a clouding effect appearing in the sol which transmits less light than normal. This may be noted by passing a beam of light through the sol as the salt solution is added and estimating by eye the change towards a cloudiness, or an electric photometer may be used. A particular sol is made of the pigskin gelatin and various solutions of sodium sulphate in water are added thereto. Referring to Fig. 4, with a starting point of any place on line 23, that is to say any sol of gelatin and water having less than 20% gelatin content, by weight, the aqueous sodium sulphate solution is added. For instance, if a 10% gelatin in water sol is used, the starting point would be 24 (Fig. 4) on line 23. If now a 15% solution of sodium sulphate in water, as would be plotted at point 25, is added slowly which would be plotted along the dotted line 26, at point 27 a clouding effect will be noticed which means that the gelatin in water S01 is changing so that the entire mass of gelatin in a liquid phase is contracted because of the increased interaction between the gelatin molecules. This clouding efi'ect, [first noticed at point 27, will continue as more of the sodium sulphate solution is added. During the experiinents to determine the coacervate line 28 by various experiments with different concentrations of sol and salt solution, the ingredients are kept at about 50 centigrade. As another example in determining the line 28 of Fig. 4, a 17 /2% sol of gelatin in water, represented by point 29, is treated with a l2 /z% solution of sodium sulphate in water as represented by point 30. As this sodium sulphate solution is added to the aqueous gelatin sol, the addition takes the mixture along the line 31 toward point 30, the clouding effect of coacervation becoming apparent at point 32. By making a number of such experimental additions of the sodium sulphate solution to various sol concentrations, the contour of line 28 may be ascertained and the ranges within which coacervation occurs by the addition of sodium sulphate solution to the gelatin sol may be ascertained. The region to the right of line 28 is the coacervate region of the mixture but the addition of salt solution should not be carried far past the line 28 in actual practice, the more salt solution added the more aggregation occurring until a lumpy mass is formed. In a similar manner the line 33 of Fig. 5 may be determined by the use of ammonium sulphate solution.
It will be evident that the ammonium sulphate solution is not as efiicient in action as the sodium sulphate solution and the same dilferences occur with other salts. Useful salts for coacervation may be made from the cations Na K Rb Cs NH Li and the anions S04 citrate tartrate acetate Cl such being arranged in the order of their eifectiveness in this process.
When oil droplets are present the gelatin still in the liquid phase starts to draw together entrapping the oil droplets by deposition of the sol material around them individually as nuclei, forming a strong shell-like wall, and upon gelation of the colloid material the capsules are complete.-
Reference has been made to the fact that the size of the pores in the encapsulated material may be controlled during the gelling process. The faster the gelation of the colloid the finer the pore size of the gelled structure will be, and vice versa. As was said with reference to Fig. 3, the gelation of the gelatin was accomplished by pouring the coacervated mixture, amounting to about a gallon and a half, into gallons of relatively cool water-l9 centigrade. This causes rapid cooling and rapid gelation of the gelatin, resulting in a pore size so small that the encapsulated trichlorodiphenyl cannot escape through the capsule walls. Less rapid cooling will result in pores of larger size and the oil used may gradually escape or not as is determined by the size of the pores in the encapsulating film and the size of the oil molecules. That capsules made in accordance with the process of Fig. 3 actually retain the trichlorodiphenyl oil has been proved in various Ways. Some of the dried capsular material was placed in a Soxhlet extractor with toluene and subjected to extraction for a week. The material was then removed and dried. Upon crushing the capsular material, oil was released. In another instance paper which had been coated with a film of the capsular material containing 3,3 bis (p-dimethylaminophenyl) 6-dirnethylamino phthalide in the oil droplets was similarly treated in the Soxhlet extractor. Upon removal and drying, it was used as a transfer sheet by placing it over a paper coated with attapulgite clay. It made marks on the clay-coated sheet when subjected to printing and writing pressures, that were as good as those made with an amount of unprotected oil equal to that in the paper. Whereas the unprotected 6 oil evaporated one day, there was no evidence of any loss of oil from the paper, even though left in the oven for over days at the same temperature.
While the invention, including the ingredients and steps, has been fully outlined in the foregoing specification, the steps are capable of some modification in regard to temperature and amounts of ingredients used, and the ingredients themselves, of course, may be changed, as indicated earlier in the specification.
What is claimed is:
l. The method of making oil-containing microscopic capsules of gellable hydrophilic colloid material, including the steps of making an aqueous sol of a gellable hydrophilic colloid material; emulsifying therein an oil; adding and stirring into the emulsion a previously determined aqueous coacervate salt soluiton, of such concentration and in such amount as to bring the emulsion into the coacervate region defined by the occurrence of a clouding effect when the aqueous salt solution is added to the colloid solution in the absence of oil, all of the fore going steps being carried out at a temperature above the gelation point of the colloid material, whereby the colloid material deposits around each oil droplet by coacervate forces, encapsulating each of them; and gelling the colloid material by cooling.
2. The method of claim 1 in which the colloid used is gelatin.
3. The method of claim 1 in which the salt is sodium sulphate.
4. The method of claim '1 in which the colloid material is gelatin and the salt is sodium sulphate.
5. The method of claim 1 in which the salt is ammonium sulphate.
6. The method of claim 1 in which the colloid material is gelatin and the salt ammonium sulphate.
7. The method of claim 1 in which the steps before gelation are carried out above the gelation point of the colloid and the pore size of the capsular material around the oil droplets is made small by the rapid cooling of the coacervate material to cause rapid gelation of the colloid.
8. Oil-containing microscopic capsules made according to the method of claim 1..
9. Oil-containing microscopic capsules made according to the method of claim 2.
l0. Oil-containing microscopic capsules made according to the method of claim 3.
11. Oil-containing microscopic capsules made according to the method of claim 4.
12. Oil-containing microscopic capsules made according to the method of claim 5.
13. Oil-containing microscopic capsules made according to the method of claim 6.
14. Oil-containing microscopic capsules made according to the method of claim 7.
15. The method of making oil-containing microscopic capsules of gellable hydrophilic colloid material, including the steps of forming an emulsion of oil and an aqueous sol of gellable hydrophilic colloid material, then changing the condition of the resultant oil-containing sol to increase interaction between colloid molecules of said sol and bring said sol into the coacervate region wherein said colloid material contracts as a colloid-rich coacervate, the said region being defined by the occurrence of a clouding efiect when the condition of the same c olloid sol is changed in the some way in the absence 0 oil, all of the foregoing steps being carried out at a temperature above the gelation point of the colloid material, whereby coacervate colloid material deposits around each oil droplet encapsulating each of them, and gelling the encapsulating colloid material by cooling.
16. Oil-containing microscopic capsules made according to the method of claim 15.
17. The method of claim 15, in which said cooling is with agitation.
18. Oil-containing,microscopic capsules made accord- 12,730,457 ing to the method of claim 17. 2,800,457
References Cited in the file of this patent or the original patent 5 514 047 UNITED STATES PATENTS 454,3 5
2,183,053 Taylor Dec. 12, 1939 2,410,110 Taylor Oct. 26, 1946 2,714,375 Sandberg June 21, 1955 '8 Green et al. Jan. 10, 1956 Green et a1. July 23, 1957 FOREIGN PATENTS Great Britain Oct. 30, 1939 Germany Jan. 6, 1928 OTHER REFERENCES Emulsion Technology (1946,) pages 26, 68, 69.
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US3092553 *||11 Apr 1960||4 Jun 1963||Jr Carl E Fisher||Pharmaceutical preparations and method and apparatus for making same|
|US3238103 *||26 Apr 1961||1 Mar 1966||Vogenthaler Clarence A||Therapeutic composition and method of making it|
|US3455848 *||5 May 1964||15 Jul 1969||Ncr Co||Polyurethane foam-producing compositions comprising microencapsulated particles and a method of making foams therefrom|
|US3460972 *||29 Sep 1965||12 Aug 1969||Battelle Development Corp||Liquid encapsulation|
|US3469439 *||21 Feb 1968||30 Sep 1969||Felton Lewis P||Means for measuring distributed forces using microcapsules|
|US5035896 *||15 Jun 1988||30 Jul 1991||Warner-Lambert Company||Water insoluble drugs coated by coacervated fish gelatin|
|US5447728 *||16 Dec 1993||5 Sep 1995||Emisphere Technologies, Inc.||Desferrioxamine oral delivery system|
|US5540939||25 Apr 1994||30 Jul 1996||Emisphere Technologies, Inc.||Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof|
|US5541155||22 Apr 1994||30 Jul 1996||Emisphere Technologies, Inc.||Acids and acid salts and their use in delivery systems|
|US5578323 *||14 Jun 1993||26 Nov 1996||Emisphere Technologies, Inc.||Proteinoid carriers and methods for preparation and use thereof|
|US5601846 *||9 May 1995||11 Feb 1997||Emisphere Technologies, Inc.||Proteinoid microspheres and methods for preparation and use thereof|
|US5603952 *||30 Dec 1994||18 Feb 1997||Tastemaker||Method of encapsulating food or flavor particles using warm water fish gelatin, and capsules produced therefrom|
|US5616315 *||13 Oct 1994||1 Apr 1997||Gillette Canada Inc.||Particles including degradable material and anti-microbial agent|
|US5629020 *||22 Apr 1994||13 May 1997||Emisphere Technologies, Inc.||Modified amino acids for drug delivery|
|US5643957 *||25 Oct 1994||1 Jul 1997||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US5650386||31 Mar 1995||22 Jul 1997||Emisphere Technologies, Inc.||Compositions for oral delivery of active agents|
|US5660817||9 Nov 1994||26 Aug 1997||Gillette Canada, Inc.||Desensitizing teeth with degradable particles|
|US5667806||7 Jun 1995||16 Sep 1997||Emisphere Technologies, Inc.||Spray drying method and apparatus|
|US5693338||29 Sep 1994||2 Dec 1997||Emisphere Technologies, Inc.||Diketopiperazine-based delivery systems|
|US5709861 *||13 Jan 1995||20 Jan 1998||Emisphere Technologies, Inc.||Compositions for the delivery of antigens|
|US5714167 *||25 Oct 1994||3 Feb 1998||Emisphere Technologies, Inc.||Active agent transport systems|
|US5741479||6 Jun 1995||21 Apr 1998||Gillette Canada Inc.||Desensitizing teeth with degradable particles|
|US5750147||7 Jun 1995||12 May 1998||Emisphere Technologies, Inc.||Method of solubilizing and encapsulating itraconazole|
|US5766633||22 Apr 1994||16 Jun 1998||Emisphere Technologies, Inc.||Oral drug delivery compositions and methods|
|US5792451 *||2 Mar 1994||11 Aug 1998||Emisphere Technologies, Inc.||Oral drug delivery compositions and methods|
|US5804688 *||7 Feb 1997||8 Sep 1998||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US5811127 *||24 Oct 1994||22 Sep 1998||Emisphere Technologies, Inc.||Desferrioxamine oral delivery system|
|US5820881 *||28 Apr 1995||13 Oct 1998||Emisphere Technologies, Inc.||Microspheres of diamide-dicarboxylic acids|
|US5824345 *||7 Jun 1995||20 Oct 1998||Emisphere Technologies, Inc.||Fragrances and flavorants|
|US5840340 *||30 Aug 1996||24 Nov 1998||Emisphere Technologies, Inc.||Proteinoid carriers and methods for preparation and use thereof|
|US5863944||30 Apr 1997||26 Jan 1999||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US5866536 *||6 Feb 1997||2 Feb 1999||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US5876710 *||7 Feb 1997||2 Mar 1999||Emisphere Technologies Inc.||Compounds and compositions for delivering active agents|
|US5879681 *||7 Feb 1997||9 Mar 1999||Emisphere Technolgies Inc.||Compounds and compositions for delivering active agents|
|US5935601 *||21 Apr 1995||10 Aug 1999||Emisphere Technologies, Inc.||Modified amino acids for drug delivery|
|US5939381||7 Feb 1997||17 Aug 1999||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US5955503 *||6 Feb 1997||21 Sep 1999||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US5958457 *||10 May 1995||28 Sep 1999||Emisphere Technologies, Inc.||Compositions for the delivery of antigens|
|US5962710||9 May 1997||5 Oct 1999||Emisphere Technologies, Inc.||Method of preparing salicyloylamino acids|
|US5965121||6 Feb 1997||12 Oct 1999||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US5972387||21 Nov 1994||26 Oct 1999||Emisphere Technologies, Inc.||Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof|
|US5976569||29 Apr 1997||2 Nov 1999||Emisphere Technologies, Inc.||Diketopiperazine-based delivery systems|
|US5989539||6 Feb 1997||23 Nov 1999||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US5990166||7 Feb 1997||23 Nov 1999||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US6051258||7 Jun 1995||18 Apr 2000||Emisphere Technologies, Inc.||Proteinoid emulsions and methods for preparation and use thereof|
|US6060513||7 Feb 1997||9 May 2000||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US6071510||23 Apr 1997||6 Jun 2000||Emisphere Technologies, Inc.||Modified amino acids and compositions comprising the same for delivering active agents|
|US6071538 *||30 Sep 1997||6 Jun 2000||Emisphere Technologies, Inc.||Oral delivery composition comprising supramolecular complex|
|US6084112||10 Sep 1996||4 Jul 2000||Emisphere Technologies, Inc.||Method for preparing ω-aminoalkanoic acid derivatives from cycloalkanones|
|US6090958||7 Feb 1997||18 Jul 2000||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US6099856 *||10 Dec 1996||8 Aug 2000||Emisphere Technologies, Inc.||Active agent transport systems|
|US6100285||11 Nov 1997||8 Aug 2000||Emisphere Technologies, Inc.||Method of solubilizing itraconazole|
|US6100298 *||6 Feb 1997||8 Aug 2000||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US6180140||2 Jun 1995||30 Jan 2001||Emisphere Technologies, Inc.||Modified amino acids for drug delivery|
|US6221367||29 Sep 1997||24 Apr 2001||Emisphere Technologies, Inc.||Active agent transport systems|
|US6242495||16 Jun 2000||5 Jun 2001||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US6245359||30 Sep 1997||12 Jun 2001||Emisphere Technologies, Inc.||Active agent transport systems|
|US6313088||7 Feb 1997||6 Nov 2001||Emisphere Technologies, Inc.||8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents|
|US6331318||30 Sep 1994||18 Dec 2001||Emisphere Technologies Inc.||Carbon-substituted diketopiperazine delivery systems|
|US6346242||8 Feb 2000||12 Feb 2002||Emishpere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US6348207||30 Sep 1997||19 Feb 2002||Emisiphere Technologies, Inc.||Orally deliverable supramolecular complex|
|US6375872||17 Nov 1992||23 Apr 2002||Moore Business Forms||Microencapsulated adhesive|
|US6375983||12 Jun 1997||23 Apr 2002||Emisphere Technologies, Inc.||Microencapsulated fragrances and method for preparation|
|US6413550||23 Nov 1998||2 Jul 2002||Emisphere Technologies, Inc.||Proteinoid carriers and methods for preparation and use thereof|
|US6428780||5 May 1999||6 Aug 2002||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US6461545||6 Jan 2000||8 Oct 2002||Emisphere Technologies, Inc.||Method of solubilizing and encapsulating itraconazole|
|US6475542 *||8 Jan 1997||5 Nov 2002||Ajinomoto Co., Inc.||Edible microcapsule and food containing the same|
|US6592916||22 Jul 2002||15 Jul 2003||Ajinomoto Co., Inc.||Edible microcapsule and food containing the same|
|US7417022||11 Apr 2005||26 Aug 2008||Mhr Institutional Partners Iia Lp||Compounds and compositions for delivering active agents|
|US7553872||13 Feb 2006||30 Jun 2009||Emisphere Technologies, Inc.||Compounds and compositions for delivering active agents|
|US8053494||10 Jan 2008||8 Nov 2011||Nocopi Technologies, Inc.||Invisible ink and scratch pad|
|US8927026||4 Apr 2012||6 Jan 2015||The Procter & Gamble Company||Shampoo compositions with increased deposition of polyacrylate microcapsules|
|US8980292||4 Apr 2012||17 Mar 2015||The Procter & Gamble Company||Conditioner compositions with increased deposition of polyacrylate microcapsules|
|US9162085||4 Apr 2012||20 Oct 2015||The Procter & Gamble Company||Personal cleansing compositions with increased deposition of polyacrylate microcapsules|
|US9186642||11 May 2010||17 Nov 2015||The Procter & Gamble Company||Delivery particle|
|US9561169||9 Feb 2015||7 Feb 2017||The Procter & Gamble Company||Conditioner compositions with increased deposition of polyacrylate microcapsules|
|US20050075420 *||15 Sep 2004||7 Apr 2005||Terry Stovold||Invisible ink|
|US20050165131 *||18 Mar 2005||28 Jul 2005||Terry Stovold||Invisible ink|
|US20080113862 *||10 Jan 2008||15 May 2008||Nocopi Technologies, Inc.||Invisible Ink And Scratch Pad|
|U.S. Classification||428/402.2, 514/784, 106/14.5, 264/4.4, 106/31.14, 424/492, 252/363.5, 106/31.24, 264/4.3, 106/124.1|
|International Classification||B01J13/10, B01J13/08, A61K9/50, B41J13/10, B41M5/165|
|Cooperative Classification||A61K9/5089, B01J13/10, B01J13/08, Y10S101/29, B41J13/10, B41M5/165|
|European Classification||B01J13/08, B41J13/10, B01J13/10, B41M5/165, A61K9/50P|